Apollo Endosurgery, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Apollo Endosurgery, Inc. | APEN - |
Last Trade $8.48 |
$7.75 |
$0.00 | 8.4 million | 10/13/2021 |
Piper Sandler, Cowen, Stifel
|
Co-Manager(s): Craig-Hallum Capital, Lake Street
|
|
Filing(s): |
For IPO Boutique's "scale of 1 to 5" BUY rating on Apollo Endosurgery, Inc., and our comprehensive analysis, click "Buy Market Research".
Apollo Endosurgery, Inc. Quote & Chart - Click for current quote -
APEN
About Apollo Endosurgery, Inc. (adapted from Apollo Endosurgery, Inc. prospectus):
They are a medical technology company focused on less invasive therapies for the treatment of obesity, a condition facing over 650 million people globally, as well as other gastrointestinal conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "APEN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved